Xeris Biopharma Holdings, Inc. XERS EPS (Basic)
EPS (Basic) at other companies
Other financials
Where this comes from
Reported directly by Xeris Biopharma Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.
The official record: Xeris Biopharma Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xeris Biopharma Holdings, Inc.'s eps (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xeris Biopharma Holdings, Inc.'s EPS (basic)?
- Xeris Biopharma Holdings, Inc. (XERS) reported EPS (basic) of $0.01 in Q1 2026.
- How has Xeris Biopharma Holdings, Inc.'s EPS (basic) changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s EPS (basic) increased by 116.7% year-over-year, from -$0.06 to $0.01.
- What is the long-term trend for Xeris Biopharma Holdings, Inc.'s EPS (basic)?
- Over 4 years (2021 to 2025), Xeris Biopharma Holdings, Inc.'s EPS (basic) has grown at a -100.0% compound annual growth rate (CAGR), from -$1.54 to $0.00.
- What does EPS (basic) mean?
- Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.